Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial

Ju Hee Oh, Dae Won Jun, Hye Young Kim, Seung Min Lee, Eileen L. Yoon, Jungwook Hwang, Jung Hwan Park, Hanbi Lee, Wankyu Kim, Hyunsung Kim

Clin Mol Hepatol. 2022;28(3):497-509. Published online April 28, 2022

DOI: https://doi.org/10.3350/cmh.2022.0019

View: 1342 Download: 88

Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals

Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, Jieling Xiao, Phoebe Tay, Margaret Teng, Keng Siang Lee, Snow Yunni Lin, May Zin Myint, Benjamin Tan, Vijay K Sharma, Darren Jun Hao Tan, Wen Hui Lim, Apichat Kaewdech, Daniel Huang, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Muthiah, Cheng Han Ng

Clin Mol Hepatol. 2022;28(3):483-496. Published online March 2, 2022

DOI: https://doi.org/10.3350/cmh.2021.0406

View: 2265 Download: 155 Citations: 7

Editorial

A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease

Seonghwan Hwang, Won Kim

Clin Mol Hepatol. 2022;28(3):478-480. Published online June 16, 2022

DOI: https://doi.org/10.3350/cmh.2022.0143

View: 857 Download: 39

Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?

Qian Jin, Rui-Xu Yang, Jian-Gao Fan

Clin Mol Hepatol. 2022;28(3):473-477. Published online June 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0155

View: 864 Download: 51

Review

Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases

Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim

Clin Mol Hepatol. 2022;28(3):425-472. Published online July 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0186

View: 1863 Download: 142

Original Article

Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods

Seung Mi Lee, Suhyun Hwangbo, Errol R. Norwitz, Ja Nam Koo, Ig Hwan Oh, Eun Saem Choi, Young Mi Jung, Sun Min Kim, Byoung Jae Kim, Sang Youn Kim, Gyoung Min Kim, Won Kim, Sae Kyung Joo, Sue Shin, Chan-Wook Park, Taesung Park, Joong Shin Park

Clin Mol Hepatol. 2022;28(1):105-116. Published online October 15, 2021

DOI: https://doi.org/10.3350/cmh.2021.0174

View: 2870 Download: 134 Citation: 1

Editorial

Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?

Seung Mi Lee, Won Kim

Clin Mol Hepatol. 2022;28(1):47-49. Published online November 30, 2021

DOI: https://doi.org/10.3350/cmh.2021.0338

View: 1617 Download: 70

Original Article

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis

Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding

Clin Mol Hepatol. 2021;27(2):329-345. Published online January 20, 2021

DOI: https://doi.org/10.3350/cmh.2020.0261

View: 3222 Download: 176 Citations: 5

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis

Na Young Lee, Min Jea Shin, Gi Soo Youn, Sang Jun Yoon, Ye Rin Choi, Hyeong Seop Kim, Haripriya Gupta, Sang Hak Han, Byoung Kook Kim, Do Yup Lee, Tae Sik Park, Hotaik Sung, Byung Yong Kim, Ki Tae Suk

Clin Mol Hepatol. 2021;27(1):110-124. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0125

View: 5031 Download: 335 Citations: 23

Review

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective

Gwyneth Soon, Aileen Wee

Clin Mol Hepatol. 2021;27(1):44-57. Published online November 19, 2020

DOI: https://doi.org/10.3350/cmh.2020.0181

View: 8340 Download: 277 Citations: 8

Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2020;26(4):461-475. Published online September 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0136

View: 4837 Download: 224 Citations: 19

Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH

Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray

Clin Mol Hepatol. 2020;26(4):383-400. Published online July 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0067

View: 6069 Download: 436 Citations: 26

Original Article

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B

Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang

Clin Mol Hepatol. 2019;25(1):52-64. Published online October 23, 2018

DOI: https://doi.org/10.3350/cmh.2018.0040

View: 6077 Download: 294 Citations: 39

Review

Recent research trends and updates on nonalcoholic fatty liver disease

Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn

Clin Mol Hepatol. 2019;25(1):1-11. Published online August 8, 2018

DOI: https://doi.org/10.3350/cmh.2018.0037

View: 15186 Download: 680 Citations: 45

Original Article

Picroside II attenuates fatty acid accumulation in HepG2 cells via modulation of fatty acid uptake and synthesis

Hiteshi Dhami-Shah, Rama Vaidya, Shobha Udipi, Srividhya Raghavan, Shiny Abhijit, Viswanathan Mohan, Muthuswamy Balasubramanyam, Ashok Vaidya

Clin Mol Hepatol. 2018;24(1):77-87. Published online December 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0039

View: 10892 Download: 521 Citations: 12

Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study

Gi Hyun Kim, Jung Wha Chung, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim

Clin Mol Hepatol. 2015;21(4):379-386. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.379

View: 9741 Download: 146 Citations: 8

Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study

Kil Woo Lee, Ki Bae Bang, Eun Jung Rhee, Heon Ju Kwon, Mi Yeon Lee, Yong Kyun Cho

Clin Mol Hepatol. 2015;21(4):372-378. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.372

View: 7202 Download: 151 Citations: 32

Elevated red cell distribution width is associated with advanced fibrosis in NAFLD

Hwa Mok Kim, Bum Soo Kim, Yong Kyun Cho, Byung Ik Kim, Chong Il Sohn, Woo Kyu Jeon, Hong Joo Kim, Dong Il Park, Jung Ho Park, Kwan Joong Joo, Chang Joon Kim, Yong Sung Kim, Woon Je Heo, Won Seok Choi

Clin Mol Hepatol. 2013;19(3):258-265. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.258

View: 7477 Download: 86 Citations: 27

The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults

Deok Yun Ju, Young Gil Choe, Yong Kyun Cho, Dong Suk Shin, Su Hyeon Yoo, Seo Hyoung Yim, Ji Yong Lee, Jung Ho Park, Hong Joo Kim, Dong Il Park, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim

Clin Mol Hepatol. 2013;19(2):140-147. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.140

View: 6174 Download: 71 Citations: 14

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease

Young Seok Kim, Eun Sun Jung, Wonhee Hur, Si Hyun Bae, Jong Young Choi, Myeong Jun Song, Chang Wook Kim, Se Hyun Jo, Chang Don Lee, Young Sok Lee, Sang Wook Choi, Jin Mo Yang, Jeong Won Jang, Sang Gyune Kim, Seung Won Jung, Hee Kyung Kim, Hee Bok Chae, Seung Kew Yoon

Clin Mol Hepatol. 2013;19(2):120-130. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.120

View: 8360 Download: 77 Citations: 19

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease

Min-Sun Kwak, Donghee Kim, Goh Eun Chung, Seung Joo Kang, Min Jung Park, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee

Clin Mol Hepatol. 2012;18(4):383-390. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.383

View: 10748 Download: 99 Citations: 61

Editorial

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease

Byoung Kuk Jang

Clin Mol Hepatol. 2012;18(4):357-359. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.357

View: 5418 Download: 66 Citations: 21

Original Article

Development and validation of a simple index system to predict nonalcoholic fatty liver disease

Young Jin Park, Jie Hyang Lim, Eun Ryoung Kwon, Hee Kyoung Kim, Myoung Chul Jung, Kyoung Hwan Seol, Woo Yong Noh, Na Eun Kim

Clin Mol Hepatol. 2011;17(1):19-26. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.19

View: 6324 Download: 51 Citations: 11

Editorial

Liver function tests as indicators of metabolic syndrome

Han Chu Lee

Clin Mol Hepatol. 2011;17(1):9-11. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.9

View: 4245 Download: 45 Citations: 3

Current status of Liver diseases in Korea: nonalcoholic fatty Liver disease

Sang Hoon Park

Clin Mol Hepatol. 2009;15(60):34-39. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.S6.S34

View: 6142 Download: 40 Citations: 19

2

Pathology of nonalcoholic steatohepatitis

Yoon Mi Jeen , So Young Jin

Clin Mol Hepatol. 2009;15(2):122-130. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.122

View: 4191 Download: 53 Citations: 3

1

Nonalcoholic fatty Liver disease as a risk factor of cardiovascular disease

Moon Young Kim , Soon Koo Baik

Clin Mol Hepatol. 2008;14(1):1-3. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.1

View: 3893 Download: 53 Citations: 2

3

The Prevalence of Peripheral Iron Overload and the Presence of HFE gene (H63D) Mutation among the Korean Patients with Nonalcoholic Fatty Liver Disease

Don Hun Lee , Sook Hyang Jeong , Myung Jin Lee , Young Ae Cho , Jin Wook Kim , Young Soo Park , Jin Hyuk Hwang , Na Young Kim , Doug Ho Lee

Clin Mol Hepatol. 2007;13(2):174-184. Published online January 1, 1970

View: 2587 Download: 23

5

Nonalcoholic Steatohepatitis

So-Young Jin

Clin Mol Hepatol. 2006;12(3):455-459. Published online January 1, 2000

View: 2118 Download: 18

3

A Prospective Study on the Prevalence and Clinical Significance of Autoantibodies in Patients with Suspected Nonalcholic Fatty Liver Disease

Dae Hyeon Cho, M.D. Moon Seok Choi, M.D., Dong Hee Kim, M.D., Do Young Kim, M.D., Sang Goon Shim, M.D. Joon Hyeok Lee, M.D., Kwang Cheol Koh, M.D., Seung Woon Paik, M.D., Byung Chul Yoo, M.D., and Jong Chul Rhee, M.D.

Clin Mol Hepatol. 2005;11(3):261-267. Published online January 1, 1970

View: 3016 Download: 35

1 | 2 |

Viewed By 11276	Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
Viewed By 4890	A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
Viewed By 3942	KASL clinical practice guidelines for management of chronic hepatitis B
Viewed By 2819	Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
Viewed By 2715	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Cited By 45	Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Cited By 38	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 35	Application of transient elastography in nonalcoholic fatty liver disease
Cited By 33	KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications
Cited By 33	Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Search